MedTrace Logo

Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression

NCT07363551 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-26

No results posted yet for this study

Summary

This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder

Conditions

  • ADHD

Interventions

DIETARY_SUPPLEMENT

Placebo

soy bean oil

COMBINATION_PRODUCT

Omega-3 fatty acids

omega-3 fatty acids (EPA)

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-09
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07363551 on ClinicalTrials.gov